THE SOCIETAL IMPACT OF LENALIDOMIDE IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA IN GERMANY

被引：0
|
作者：
Hofmann, S. [1 ]
Seddik, A. [1 ]
机构：
[1] WifOR, Darmstadt, HE, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN216
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 50 条
  • [31] Lenalidomide for multiple myeloma
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2010, 7 (5) : 241 - 241
  • [32] Lenalidomide in multiple myeloma
    Sirohi, Bhawna
    Powles, Ray
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (11) : 1559 - 1570
  • [33] Lenalidomide in multiple myeloma
    Thomas, Sheeba K.
    Richards, Tiffany A.
    Weber, Donna M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 717 - 735
  • [34] Lenalidomide in multiple myeloma
    Kim, Young
    Schmidt-Wolf, Ingo G. H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 491 - 497
  • [35] GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study
    Schmidts, Andrea
    Gruenewald, Julian
    Kleber, Martina
    Terpos, Evangelos
    Ihorst, Gabriele
    Reinhardt, Heike
    Walz, Gerd
    Waesch, Ralph
    Engelhardt, Monika
    Zschiedrich, Stefan
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (02) : 199 - 206
  • [36] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Shinsuke Iida
    Takaaki Chou
    Shinichiro Okamoto
    Hirokazu Nagai
    Kiyohiko Hatake
    Hirokazu Murakami
    Toshiyuki Takagi
    Kazuyuki Shimizu
    Henry Lau
    Kenichi Takeshita
    Masaaki Takatoku
    Tomomitsu Hotta
    International Journal of Hematology, 2010, 92 : 118 - 126
  • [37] GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study
    Andrea Schmidts
    Julian Grünewald
    Martina Kleber
    Evangelos Terpos
    Gabriele Ihorst
    Heike Reinhardt
    Gerd Walz
    Ralph Wäsch
    Monika Engelhardt
    Stefan Zschiedrich
    Clinical and Experimental Nephrology, 2019, 23 : 199 - 206
  • [38] TREATMENT OF ELDERLY AND FRAIL MULTIPLE MYELOMA PATIENTS WITH LOW DOSE OF LENALIDOMIDE AND DEXAMETHASONE
    Palazzo, G.
    Palumbo, G.
    Pisapia, G.
    De Donno, S.
    Leggieri, E.
    Tamburrano, A.
    Francavilla, R.
    Capalbo, S.
    Iannitto, E.
    HAEMATOLOGICA, 2012, 97 : 623 - 624
  • [39] Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis
    Wilk, Christian Matthias
    Heinzler, Niklas
    Boquoi, Amelie
    Cadeddu, Ron-Patrick
    Strapatsas, Tobias
    Dienst, Ariane
    Majidi, Fatemeh
    Deenen, Rene
    Bruns, Ingmar
    Schroeder, Thomas
    Koehrer, Karl
    Haas, Rainer
    Kobbe, Guido
    Fenk, Roland
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (10) : 2343 - 2352
  • [40] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Iida, Shinsuke
    Chou, Takaaki
    Okamoto, Shinichiro
    Nagai, Hirokazu
    Hatake, Kiyohiko
    Murakami, Hirokazu
    Takagi, Toshiyuki
    Shimizu, Kazuyuki
    Lau, Henry
    Takeshita, Kenichi
    Takatoku, Masaaki
    Hotta, Tomomitsu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 118 - 126
12345